Understanding the essential requirement for HDAC1 and HDAC2 in tissue development and homeostasis: implications for disease and therapy.

了解 HDAC1 和 HDAC2 在组织发育和稳态中的基本要求:对疾病和治疗的影响。

基本信息

  • 批准号:
    MR/J009202/1
  • 负责人:
  • 金额:
    $ 261.94万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Fellowship
  • 财政年份:
    2012
  • 资助国家:
    英国
  • 起止时间:
    2012 至 无数据
  • 项目状态:
    已结题

项目摘要

'Histone deacetylase' (HDAC) enzymes are present in all cells of the body. Their function is to switch genes 'off', and make sure they stay 'off'. My lab studies how HDACs do this and which, amongst the 25,000 genes in each cell, are selected for inactivation. HDAC enzymes also represent an exciting medical opportunity because they are 'druggable'. Already, drugs which inhibit HDAC activity are being used in the clinic as anti-cancer agents, and are being further developed for their beneficial effects on dementia and anti-inflammatory properties. There is therefore a compelling applied, as well as academic motivation for studying their physiological roles. In order to assess their potential as pharmacological targets, we need an improved understanding of how individual HDAC enzymes work in normal cells. In this study we intend study two closely related HDAC enzymes, HDAC1 and HDAC2. One of the best methods for understanding how an enzyme works is to generate mutant cells in which the specific enzyme has been inactivated, or 'knocked-out'. These 'knock-out' cells can then be examined for changes in their characteristics, lack of growth for instance, which can then be attributed to the function of that particular enzyme. Previously, we have generated 'knock-out' cells for HDAC1 and HDAC2 alone, but their function is overlapping, and so the effects on cell growth were small. To get around this, we have generated cells in which HDAC1 and 2 can be removed at the same time, so called 'double knock-out' cells. Early experiments indicate that loss of both enzymes causes cells to die, indicating that their activity is essential. Using DNA technology it is possible to add back normal or mutated forms of HDAC1 to prevent the double knock-out cells from dying and then ask, which parts of the enzyme are important for its function? In related experiments, we also intend to visualize the actual molecular structure of HDAC1 bound to a molecule called MTA1, using a technique called X-ray crystallography. The interaction of HDAC1 with other molecules in the cell is fundamental to their function. By understanding the molecular basis of these interactions we can better understand how HDAC enzymes work in normal and cancer cells, and potentially use that knowledge to design new drugs to prevent them from working. The ability to stop HDAC1 and 2 from working, as seen in our double knock-out cells, causes cells to stop growing and die, making them excellent drug targets in the search for improved anti-cancer agents.
“组蛋白脱乙酰酶”(HDAC)酶存在于身体的所有细胞中。它们的功能是“关闭”基因,并确保它们保持“关闭”状态。我的实验室研究HDAC是如何做到这一点的,以及在每个细胞的25,000个基因中,哪些基因被选择去失活。HDAC酶也代表了一个令人兴奋的医疗机会,因为它们是“药物”。抑制HDAC活性的药物已经在临床上用作抗癌剂,并且正在进一步开发其对痴呆症和抗炎特性的有益作用。因此,有一个令人信服的应用,以及学术动机,研究他们的生理作用。为了评估它们作为药理学靶点的潜力,我们需要更好地了解单个HDAC酶如何在正常细胞中工作。在这项研究中,我们打算研究两种密切相关的HDAC酶,HDAC 1和HDAC 2。了解酶如何工作的最好方法之一是产生突变细胞,其中特定的酶已经失活或“敲除”。然后可以检查这些“敲除”细胞的特征变化,例如缺乏生长,然后可以将其归因于该特定酶的功能。以前,我们已经单独产生了HDAC 1和HDAC 2的“敲除”细胞,但它们的功能是重叠的,因此对细胞生长的影响很小。为了解决这个问题,我们已经产生了可以同时去除HDAC 1和2的细胞,即所谓的“双敲除”细胞。早期的实验表明,这两种酶的缺失会导致细胞死亡,这表明它们的活性是必不可少的。使用DNA技术,可以添加正常或突变形式的HDAC 1,以防止双敲除细胞死亡,然后问,酶的哪些部分对其功能很重要?在相关的实验中,我们还打算使用一种称为X射线晶体学的技术来可视化HDAC 1与一种名为MTA 1的分子结合的实际分子结构。HDAC 1与细胞中其他分子的相互作用是其功能的基础。通过了解这些相互作用的分子基础,我们可以更好地了解HDAC酶在正常细胞和癌细胞中的工作方式,并可能利用这些知识来设计新的药物来阻止它们工作。正如我们的双敲除细胞中所看到的那样,阻止HDAC 1和2工作的能力导致细胞停止生长和死亡,使它们成为寻找改进的抗癌药物的绝佳药物靶点。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sin3A recruits Tet1 to the PAH1 domain via a highly conserved Sin3-Interaction Domain.
  • DOI:
    10.1038/s41598-018-32942-w
  • 发表时间:
    2018-10-02
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Chandru A;Bate N;Vuister GW;Cowley SM
  • 通讯作者:
    Cowley SM
Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.
  • DOI:
    10.1039/d1mo00236h
  • 发表时间:
    2022-01-17
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Barnes CE;English DM;Broderick M;Collins MO;Cowley SM
  • 通讯作者:
    Cowley SM
Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo.
  • DOI:
    10.1038/s41598-018-32927-9
  • 发表时间:
    2018-10-02
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Kelly RDW;Chandru A;Watson PJ;Song Y;Blades M;Robertson NS;Jamieson AG;Schwabe JWR;Cowley SM
  • 通讯作者:
    Cowley SM
Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells
A 'click' chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras.
  • DOI:
    10.1039/d2md00199c
  • 发表时间:
    2022-12-14
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shaun Cowley其他文献

New insights into the endothelial-to-haematopoietic transition leading to HSC emergence
  • DOI:
    10.1016/j.exphem.2015.06.043
  • 发表时间:
    2015-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Georges Lacaud;Roshana Thambyrajah;Milena Mazan;Rahima Patel;Victoria Moignard;Monika Stefanska;Elli Marinopoulou;Yaoyong Li;Christophe Lancrin;Thomas Clapes;Tarik Möröy;Catherine Robin;Crispin Miller;Shaun Cowley;Bertie Gottgens;Valerie Kouskoff
  • 通讯作者:
    Valerie Kouskoff

Shaun Cowley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shaun Cowley', 18)}}的其他基金

Understanding the unique properties of the Sin3A histone deacetylase complex in transcription and cell viability
了解 Sin3A 组蛋白脱乙酰酶复合物在转录和细胞活力方面的独特特性
  • 批准号:
    MR/W00190X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 261.94万
  • 项目类别:
    Research Grant
Bilateral BBSRC-SFI: Understanding the impact of divergent Sin3A/HDAC1 complex assemblies in gene regulation
双边 BBSRC-SFI:了解不同的 Sin3A/HDAC1 复合体组装对基因调控的影响
  • 批准号:
    BB/P021689/1
  • 财政年份:
    2017
  • 资助金额:
    $ 261.94万
  • 项目类别:
    Research Grant
Understanding the contribution of inositol phosphate signalling to class-1 HDAC complex function
了解磷酸肌醇信号传导对 1 类 HDAC 复合体功能的贡献
  • 批准号:
    BB/N002954/1
  • 财政年份:
    2016
  • 资助金额:
    $ 261.94万
  • 项目类别:
    Research Grant
Understanding the recruitment of Class I HDACs into diverse repression complexes: implications for physiological activity and therapeutic devlopment
了解 I 类 HDAC 招募到不同的抑制复合物中:对生理活动和治疗开发的影响
  • 批准号:
    BB/J009598/1
  • 财政年份:
    2012
  • 资助金额:
    $ 261.94万
  • 项目类别:
    Research Grant
Analysis of Class-I Histone Deacetylase Function in Embryonic Development, Tissue Formation and Homeostasis.
胚胎发育、组织形成和稳态中 I 类组蛋白脱乙酰酶功能的分析。
  • 批准号:
    G0600135/1
  • 财政年份:
    2007
  • 资助金额:
    $ 261.94万
  • 项目类别:
    Fellowship

相似国自然基金

DDAH/ADMA/NOS系统基因多态性与原发性高血压易感性及其机制研究
  • 批准号:
    30671149
  • 批准年份:
    2006
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

Dietary restriction and associated changes in gut microbiota to prevent Alzheimer disease
饮食限制和肠道微生物群的相关变化可预防阿尔茨海默病
  • 批准号:
    9905467
  • 财政年份:
    2019
  • 资助金额:
    $ 261.94万
  • 项目类别:
Heart Healthy Microalgae? Algal production of TAGs with high levels of PUFAs
心脏健康的微藻?
  • 批准号:
    8667273
  • 财政年份:
    2014
  • 资助金额:
    $ 261.94万
  • 项目类别:
Heart Healthy Microalgae? Algal production of TAGs with high levels of PUFAs
心脏健康的微藻?
  • 批准号:
    8837687
  • 财政年份:
    2014
  • 资助金额:
    $ 261.94万
  • 项目类别:
An in vivo Gene Deletion System for Analyzing Temporal Requirement of the Dot/Icm
用于分析 Dot/Icm 时间需求的体内基因删除系统
  • 批准号:
    7472176
  • 财政年份:
    2008
  • 资助金额:
    $ 261.94万
  • 项目类别:
Exploiting Nutrition on Delay Cataract
利用营养来延缓白内障的发生
  • 批准号:
    6998424
  • 财政年份:
    2005
  • 资助金额:
    $ 261.94万
  • 项目类别:
Exploiting Nutrition on Delay Cataract
利用营养延缓白内障发生
  • 批准号:
    6875387
  • 财政年份:
    2005
  • 资助金额:
    $ 261.94万
  • 项目类别:
Energy Expenditure and Protein Catabolism in Extremely Low birth Weight Infants
极低出生体重婴儿的能量消耗和蛋白质分解代谢
  • 批准号:
    7045230
  • 财政年份:
    2003
  • 资助金额:
    $ 261.94万
  • 项目类别:
PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU
等离子体
  • 批准号:
    6586005
  • 财政年份:
    2001
  • 资助金额:
    $ 261.94万
  • 项目类别:
PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU
等离子体
  • 批准号:
    6565710
  • 财政年份:
    2001
  • 资助金额:
    $ 261.94万
  • 项目类别:
PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU
等离子体
  • 批准号:
    6415315
  • 财政年份:
    2000
  • 资助金额:
    $ 261.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了